Schatten properties,nuclearity and minimality of phase shift invariant spaces

We extend Feichtinger's minimality property on the smallest non-trivial time-frequency shift invariant Banach space, to the quasi-Banach case. Analogous properties are deduced for certain matrix spaces.We use these results to prove that the pseudo-differential operator $\mathrm{Op}(a)$ is a Schatten-q operator from $M^{\infty }$ to $M^p$ and r-nuclear operator from $M^{\infty }$ to $M^r$ when $a\in M^r$ for suitable p, q and r in $(0,\infty ]$.     

Studies on oral bioavailability and first‐pass metabolism of withaferin A in rats using LC–MS/MS and Q‐TRAP

Withaferin A (WA) is one of the major bioactive steroidal lactones with extensive pharmacological activities present in the plant Withania somnifera. The absolute oral bioavailability of WA remains unknown and human‐related in vitro data are not available. Therefore, in the present study, the absolute oral bioavailability of WA in male rats and the in vitro screening of absorption factors by Q‐trap and LC–MS/MS analysis were conducted to explore possible clinical properties of WA. The developed and validated analytical methods were successfully applied to the pharmacokinetic studies and in vitro measurement of WA. The oral bioavailability was determined to be 32.4 ± 4.8% based on intravenous (5 mg/kg) and oral (10 mg/kg) administrations of WA in male rats. The in vitro results showed that WA could be easily transported across Caco‐2 cells and WA did not show as a substrate for P‐glycoprotein. Moreover, the stability of WA was similar between male rat and human in simulated gastric fluid (stable), in intestinal microflora solution (slow decrease) and in liver microsomes (rapid depletion, with a half‐life of 5.6 min). As such, the first‐pass metabolism of WA was further verified by rat intestine‐liver in situ perfusion, revealing that WA rapidly decreased and 27.1% remained within 1 h, while the content of three major metabolites (M1, M4, M5) identified by Q‐trap increased. This perfusion result is consistent with the oral bioavailability results in vivo. The first‐pass metabolism of WA might be the main barrier in achieving good oral bioavailability in male rats and it is predicted to be similar in humans. This study may hold clinical significance.     

Baclofen impurities: Facile synthesis and novel environmentally benign chromatographic method for their simultaneous determination in baclofen

An efficient, economic and high yielding method was described for the synthesis of baclofen (BAC) pharmacopoeial impurities (impurity A and impurity B) which can be used for gram‐scale synthesis. Furthermore, a novel ecofriendly thin‐layer chromatographic TLC–densitometric method was established and validated for the determination of BAC and its synthesized impurities. The developed TLC–densitometric method is based on the chromatographic separation using TLC plates (60 F₂₅₄) using a green mobile phase of ethyl acetate–methanol–ammonia solution, 33% (8:2:0.1, by volume) with UV scanning at 220 nm. The proposed method was validated with respect to International Conference on Harmonization guidelines. The validated method was successfully applied for determination of BAC in pure form and in its commercial dosage form. Additionally, the greenness profile of the developed method was evaluated and compared with those of the reported chromatographic methods. The developed method was found to be superior to the published methods, being environmentally benign.     

The Lp dual Minkowski problem for p > 1 and q > 0

General $L_p$ dual curvature measures have recently been introduced by Lutwak, Yang and Zhang [24]. These new measures unify several other geometric measures of the Brunn–Minkowski theory and the dual Brunn–Minkowski theory. $L_p$ dual curvature measures arise from qth dual intrinsic volumes by means of Alexandrov-type variational formulas. Lutwak, Yang and Zhang [24] formulated the $L_p$ dual Minkowski problem, which concerns the characterization of $L_p$ dual curvature measures. In this paper, we solve the existence part of the $L_p$ dual Minkowski problem for $p>1$ and $q>0$, and we also discuss the regularity of the solution.     

Existence of homoclinic solutions for nonlinear second-order coupled systems

This work presents sufficient conditions for the existence of homoclinic solutions for second order coupled discontinuous systems of differential equations on the real line without the usual growth condition in the literature.The arguments apply the fixed point theory, Green's functions technique, $L^1$-Carathéodory functions, lower and upper solutions and Schauder's fixed point theorem.     

A priori bounds and multiplicity for fully nonlinear equations with quadratic growth in the gradient

We consider fully nonlinear uniformly elliptic equations with quadratic growth in the gradient, such as

$?F(x,u,Du,D^{2}u)=\lambda c(x)u+〈M(x)Du,Du〉+h(x)$

in a bounded domain with a Dirichlet boundary condition; here $\lambda \in \mathbb{R}$, $c,h\in L^p(\mathrm{\Omega })$, $p>n\ge 1$, $c?0$ and the matrix M satisfies $0<{\mu }_{1}I\le M\le {\mu }_{2}I$. Recently this problem was studied in the “coercive” case $\lambda c\le 0$, where uniqueness of solutions can be expected; and it was conjectured that the solution set is more complex for noncoercive equations. This conjecture was verified in 2015 by Arcoya, de Coster, Jeanjean and Tanaka for equations in divergence form, by exploiting the integral formulation of the problem. Here we show that similar phenomena occur for general, even fully nonlinear, equations in nondivergence form. We use different techniques based on the maximum principle.We develop a new method to obtain the crucial uniform a priori bounds, which permit to us to use degree theory. This method is based on basic regularity estimates such as half-Harnack inequalities, and on a Vázquez type strong maximum principle for our kind of equations.     

A Near-Infrared-Controllable Artificial Metalloprotease Used for Degrading Amyloid-β Monomers and Aggregates

Proteolysis of amyloid-β (Aβ) is a promising approach against Alzheimer's disease. However, it is not feasible to employ natural hydrolases directly because of their cumbersome preparation and purification, poor stability, and hazardous immunogenicity. Therefore, artificial enzymes have been developed as potential alternatives to natural hydrolases. Since specific cleavage sites of Aβ are usually embedded inside the β-sheet structures that restrict access by artificial enzymes, this strongly hinders their efficiency for practical applications. Herein, we construct a NIR (near-IR) controllable artificial metalloprotease (MoS₂-Co) using a molybdenum disulfide nanosheet (MoS₂) and a cobalt complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (Codota). Evidenced by detailed experimental and theoretical studies, the NIR-enhanced MoS₂-Co can circumvent the restriction by simultaneously inhibition of β-sheet formation and destroying β-sheet structures of the preformed Aβ aggregates in living cell. Furthermore, our designed MoS₂-Co is an easy to graft Aβ-target agent that prevents misdirected or undesirable hydrolysis reactions, and has been demonstrated to cross the blood brain barrier. This method can be adapted for hydrolysis of other kinds of amyloids.